USFDA approves Zydus Lifesciences anti-fungal injection
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of
October 22, 2022: Walmart has agreed to pay Florida $215 million to settle claims that its pharmacies aided an opioid crisis in the
HQ Team October 21, 2022: Canada has recalled more than a million units of dry shampoo products of London-based Unilever after detecting a
Lupin buys two inhalation brands for $75million
Shortage of cholera vaccines forces global agencies to shift to single doses instead of recommended two
October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a “universal” method of treating Covid-19. According to
HQ Team October 19, 2022: In another eight years, about 500 million people globally will develop a spate of non-communicable diseases due to
HQ Team October 18, 2022: Hetero, an Indian pharmaceutical company, announced the acquisition of a brownfield manufacturing plant of Johnson & Johnson Private